Post-marketing surveillance and adverse drug reactions.
Shani
S
S
Pharmaceutical Policy and Economics Unit, Israel Center for Technology Assessment in Health Care, Gertner Institute for Clinical Epidemiology and Health Policy Research, Tel-Hashomer, Israel. trqsegev@matat.health.gov.il
D016907:Adverse Drug Reaction Reporting Systems / Q000191:economics; D003362:Cost-Benefit Analysis; D004335:Drug and Narcotic Control / Q000266:history; D049673:History, 20th Century; D006801:Humans; D007391:International Cooperation; D011358:Product Surveillance, Postmarketing / Q000191:economics; D014481:United States; D014486:United States Food and Drug Administration